Our research aims to obtain a comprehensive picture of how genomic stability and chromatin dynamics affect neuronal functions, including learning behaviors, and to apply this knowledge to combat neurological disorders.
Using novel multi-omics approaches and model systems to treat pancreatic cancer
Research in our laboratory is focused on the development and evaluation of various novel magnetic resonance imaging (MRI) techniques to improve diagnosis and therapy response assessment.
We study the molecular events that drive this process in a term pregnancy and how perturbation of these processes contribute to premature birth.
Medical Artificial Intelligence and Automation
We study how disseminated cancer cells survive and give rise to overt metastatic lesions.
Malloy Lab has all the tools necessary for students at all levels to lean about metabolic imaging of physiology and disease and I am excited to participate.
Malter Lab focuses on exploring and characterizing intracellular signaling pathways in the immune and nervous systems and identifying how defects/abnormalities can lead to disease.
The Mangelsdorf/Kliewer Lab studies two signal transduction pathways that offer new therapeutic potential for treating diseases such as diabetes, obesity, cancer, and parasitism.
The overall focus of the Ram Mani Lab is to study the molecular genetic and epigenetic events associated with cancer development.
The Marciano laboratory investigates fundamental aspects of kidney development and regeneration, in both health and disease.
Our laboratory is interested in understanding how the ubiquitin-mediated protein degradation regulates gene expression and how failure of these pathways contributes to developmental disorders and diseases, such as neurodegeneration and cancer.
We are interested in understanding the deregulation of epigenetic and transcriptional pathways in human disease and in finding small molecules with therapeutic potential to normalize these gene expression patterns.
The overarching goal of Mason Lab's research is the development of prognostic imaging signatures defining biomarkers of disease progression and response to therapy.
We aim to elucidate the role of the innate immune system in damage and repair following ischemic and hemorrhagic insults to the brain. We are specifically focused on innate immune drivers of secondary injury following aneurysmal subarachnoid hemorrhage and the immune response triggered by acute intracranial pressure spikes during aneurysm rupture. We also look into promoting recovery after ischemic stroke by reprogramming microglia and peripheral myeloid cells to drive repair. In addition, we are pursuing the development of therapeutics for intraarterial immunomodulation for chronic subdural hemorrhage.
McAdams Lab at UT Southwestern focuses on functional neuro-imaging studies to examine the connection between biological, psychological, and social aspects of eating disorders.
Our goal is to identify the metabolic mechanisms that push cells to become cancerous and find new ways to inhibit them.
The McFadden lab uses genetically engineered mice and human cancer cells to identify new genes and small molecules that regulate cancer cell growth.
The Meeks Lab studies olfactory neural circuits that are involved in establishing and modifying mammalian social behaviors.
The Mendell laboratory investigates fundamental aspects of post-transcriptional gene regulation, noncoding RNA regulation and function, and the roles of these pathways in normal physiology, cancer, and other diseases.
The mission in the Meng Lab is to develop a better understanding of how fundamental alterations to cell polarity contribute towards development of invasive disease in kidney cancer.
Michaely Lab focuses on the function of the proteins that control plasma membrane function. We have on-going projects investigating ARH/LDLR endocytosis and caveolae signal transduction.
Minassian Lab has been involved in the identification and co-discovery of the causative gene mutations in over 20 different childhood neurological diseases.
The main focus of the Minna Lab is translational (“bench to bedside”) cancer research aimed at developing new ways to diagnose, prevent, and treat lung cancer based on a detailed understanding of the molecular pathogenesis of lung cancer.
